DJIA 17,745.98 -5.41 -0.03%
NASDAQ 5,128.79 17.05 0.33%
S&P 500 2,108.63 0.06 0.00%
market minute promo

AbbVie Inc. (NYSE: ABBV)

70.16 -0.61 (-0.86%)

Quote as of


company name or ticker

Recent Quotes

ABBV $70.16 -0.86%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $70.86
Previous Close $70.77
Daily Range $69.27 - $70.88
52-Week Range $51.37 - $71.60
Market Cap $111.8B
P/E Ratio 44.23
Dividend (Yield) $2.04 (2.9%)
Ex-Dividend Date
Dividend Pay Date
07/13/15
08/14/15
Volume 6,820,341
Average Daily Volume 8,749,009
Current FY EPS $4.26

Sector

Industry

AbbVie Inc. (ABBV) Description

AbbVie Inc. Website: http://www.abbvie.com/

News & Commentary

Gilead's Hepatitis C Dominance Unchecked By AbbVie

Gilead Sciences blockbuster second-quarter results show that it's been little dented by the rollout of AbbVie's Viekira Pak.

AbbVie Poised For Continued Success

The Zacks Analyst Blog Highlights: Biogen, AbbVie, Regeneron, Amgen and XOMA - Press Releases

Gilead Beats And Raises Again: Why I've Stayed Overweight

Gilead Beats And Raises: Thinking Through The Future Of Its Business And Its Stock Price

Gilead (GILD) Beats on Q2 Earnings, Raises 2015 Outlook - Analyst Blog

AbbVie (ABBV) Stock Price Target Raised at Deutsche Bank

Gilead Sciences Beats And Guidance Raise Give It Room To Run Upward

A Dividend Growth Stock Portfolio For July 27, 2015

The Zacks Analyst Blog Highlights: Gilead Sciences, AbbVie, Merck, Achillion Pharmaceuticals and Exp

The Zacks Analyst Blog Highlights: Gilead Sciences, AbbVie, Merck, Achillion Pharmaceuticals and Express Scripts - Press Releases

See More ABBV News...